Published February 13, 2023 | Version 1.0.0
Dataset Open

Screening for nucleoside inhibitors of the SARS-CoV-2 RdRP

  • 1. Janssen Pharmaceutica NV


This report describes the most relevant results of screening compounds with a nucleoside analogue structure from the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 in a cell-based assay and nucleoside triphosphates in a radioactive filtering binding RdRP assay.


Files (298.5 kB)